BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for CRP LX and CRP HS to cobas 6000<cc> und cobas 6000<cce>, Roche

Product group In-vitro diagnostics
Reference 04300/07

Corrective action of Roche Diagnostics for CRP LX and CRP HS to cobas 6000<cc> und cobas 6000<cce> because of potential false results. The customers were informed about the problem and how to avoid it.

Advisory Notice is only available in German language.

Corrective action for CRP LX and CRP HS to cobas 6000<cc> und cobas 6000<cce>, Roche , Download_VeroeffentlichtAm_EN PDF, 736KB, File does not meet accessibility standards